Cargando…
Pilot Study to Evaluate the Effect of Topical Dimethicone on Clinical Signs and Skin Barrier Function in Dogs with Naturally Occurring Atopic Dermatitis
This study investigated the effects of a skin protectant solution (dimethicone 2%) on clinical signs and skin barrier function in canine atopic dermatitis (AD). Eighteen dogs with AD were randomly divided into two groups, one received dimethicone and the other received the vehicle (cyclomethicone) o...
Autores principales: | Pellicoro, C., Marsella, R., Ahrens, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654275/ https://www.ncbi.nlm.nih.gov/pubmed/23710417 http://dx.doi.org/10.1155/2013/239186 |
Ejemplares similares
-
Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitis
por: Marsella, Rosanna, et al.
Publicado: (2020) -
Evaluation of the effect of a 0.0584% hydrocortisone aceponate spray on clinical signs and skin barrier function in dogs with atopic dermatitis
por: Nam, Eui-Hwa, et al.
Publicado: (2012) -
Dietary Intervention Alleviates Signs of Atopic Dermatitis in Dogs by Improving Gut, Skin and Systemic Immunity
por: Badri, Dayakar, et al.
Publicado: (2022) -
Skin barrier in atopic dermatitis: beyond filaggrin
por: Zaniboni, Mariana Colombini, et al.
Publicado: (2016) -
Significance of Skin Barrier Dysfunction in Atopic Dermatitis
por: Kim, Byung Eui, et al.
Publicado: (2018)